Previous Topic

Next Topic

Book Contents

The process of configuring drug reallocation

Drug reallocation occurs after the drug units are improperly dispensed, so these edits are acknowledged rather than approved. However, the process is similar to approval.

Important: Drug reallocations in unblinded studies must be acknowledged by an unblinded role.

During configuration, you complete each of these tasks:

  1. Authorize drug reallocation for the study.

    This procedure switches on the ability for users of IRT for this study to reallocate drugs after a transaction is complete.

  2. Identify specific properties and permissions.

    You can identify the conditions when acknowledgment is required (never, always, or only during incorrect drug supply transactions).

    You can also identify the unblinded role that should acknowledge the request to reallocate drugs.

    A subject affected by a request for approval is locked (Locked subject) until the request is reviewed and either approved or rejected.

Send Feedback